Tel Aviv, Israel

Srinivas Ramishetti

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Srinivas Ramishetti

Introduction

Srinivas Ramishetti is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical technology, particularly in the treatment of leukocyte-related diseases. With a total of 3 patents, his work focuses on innovative methods for delivering nucleic acid molecules to leukocytes.

Latest Patents

One of his latest patents is titled "Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles." This invention discloses targeted lipid-based particles designed for the delivery of nucleic acid molecules, such as siRNA, to leukocytes, including T-Cells and B-cells. The targeted lipid particles are intended for treating leukocyte-associated diseases, such as cancer. Another significant patent is "Cationic lipids for nucleic acid delivery and preparation thereof." This invention provides cationic lipids and lipid nanoparticle formulations that facilitate the intracellular delivery of nucleic acids, both in vitro and for therapeutic applications. It also includes methods for the chemical synthesis of these lipids and the preparation of lipid nanoparticles.

Career Highlights

Srinivas Ramishetti is associated with Ramot at Tel Aviv University Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

He has collaborated with notable colleagues, including Dan Peer and Shiri Weinstein, contributing to the advancement of his research and innovations in the field.

Conclusion

Srinivas Ramishetti's contributions to medical technology through his patents highlight his innovative approach to treating leukocyte-related diseases. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…